Press Releases
31.10.2024
BRAIN Biotech AG and Akribion Therapeutics GmbH sign exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology
Corporate
Show Article
08.10.2024
BRAIN Biotech and Biodiscovery: Strategic partnership expands access to untapped enzymes for industrial application via MetXtra™
Technology
Show Article
03.10.2024
Prof. Dr. Wiltrud Treffenfeldt leaves Supervisory Board of BRAIN Biotech AG for personal reasons
Corporate
Show Article
01.10.2024
BRAIN Biotech AG and Biocatalysts Ltd Launch a New Initiative to Revolutionize Enzyme Solutions within the Life Science Industry
Corporate
Show Article
20.09.2024
BRAIN Biotech AG concludes major pharma compound transaction valued up to EUR 128.88 million from its BioIncubator
Corporate
Finance
Show Article
16.09.2024
Biocatalysts Ltd Launches Lipomod™ 70MDP - Setting A New Standard To Deliver Sustainable Solutions for Oleochemicals Industry with Maximal Production Efficiency
Products
Show Article
29.08.2024
BRAIN Biotech AG presents strong cash position with its 9M reporting and is forecasting good sequential growth in the final quarter of the business year
Finance
Show Article
22.08.2024
BRAIN Biotech AG launches the innovative technology platform MetXtra™ enabling unique enzyme solutions
Technology
Show Article
29.05.2024
BRAIN Biotech AG announces the appointment of Erik de Vries as Senior Business Development Director Enzymes
Corporate
Show Article